iShares Global Healthcare ETF (IXJ) Review & Analysis
- +2.0% in September (total return), ahead of the median international shares ETF at +0.0%.
- Investors added a net $11m (0.7% of the fund).
- The unit price closed the month at $147.08, 4% below its 12-month high (range $124.74 to $153.20).
About IXJ
IXJ is the iShares Global Healthcare ETF. It tracks the S&P Global 1200 Health Care Sector Index, holding around a hundred of the world's largest health care companies, including drug makers, medical device companies and health insurers. It is passive and unhedged.
The fund is led by large US and European groups such as Eli Lilly, Johnson & Johnson, AbbVie, Merck, Roche and Novartis, and most of the money is in the US. Health care tends to be more defensive than the broad market, as people need medicines and treatment in good times and bad, though individual companies face risks from drug trials, patent expiries and government pricing pressure. Income is modest and unfranked. Being unhedged, returns move with the US dollar.
IXJ is often used as a sector satellite, either to add a defensive tilt or to back long term trends such as ageing populations. Alternatives include DRUG and broad global funds such as VGS. See IXJ vs DRUG and VGS vs IXJ.
IXJ distributions and dividend dates
IXJ pays distributions half-yearly, usually going ex-distribution in July and December, with payment about 11 days after the ex-date.
The latest distribution was $1.5397 per unit (0% franked), ex-distribution on 1 July 2026 and paid on 13 July 2026. To receive it you need to own IXJ before the ex-date.
Its distribution yield over the past 12 months is about 1.4%. Distributions vary and past payments are not a guide to future ones.
From ASX announcements, updated nightly. See every ETF in the dividend calendar.
Compare IXJ with
| Fee | 0.41% | 0.57% |
| 1 year | +14.9% | +21.1% |
| 5 yrs p.a. | +5.9% | +4.9% |
| Size | $1.5bn | $173m |
| Fee | 0.41% | 0.18% |
| 1 year | +14.9% | +10.1% |
| 5 yrs p.a. | +5.9% | +11.8% |
| Size | $1.5bn | $18.7bn |
| Fee | 0.41% | 0.45% |
| 1 year | +14.9% | +5.5% |
| 5 yrs p.a. | +5.9% | β0.1% |
| Size | $1.5bn | $59m |
| Fee | 0.41% | 0.04% |
| 1 year | +14.9% | +10.1% |
| 5 yrs p.a. | +5.9% | +13.4% |
| Size | $1.5bn | $14.9bn |
IXJ price by TradingView
| Stock Code | IXJ |
|---|---|
| Fund Manager | iShares |
| Asset Class | International shares |
| AUM | $1.5bn |
| MER (%) | 0.41% |
| Net flows (Sep) | +$11m |
| Last Price | $147.08 |
| 52-Week Range | $124.74 β $153.20 |
| Bid/Ask Spread | 0.04% |
| Listing Date | 11/03/2009 |
| Exchange | ASX |
| Index tracked | S&P Global 1200 Healthcare Sector Index |
| Issuer website | iShares β |
Performance (% return)
$10,000 investedβ¦
Value at 30 September 2026 with distributions reinvested, before tax and brokerage.
Total returns including distributions, to 30 September 2026. 1M, 1Y, 3Y and 5Y bars are cumulative.